Multi‐Enzyme Co‐Expressed Nanomedicine for Anti‐Metastasis Tumor Therapy by Up‐Regulating Cellular Oxidative Stress and Depleting Cholesterol
Advanced Materials · 2024
DOI: 10.1002/adma.202307752 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2024. Verfasst von Yang Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin, 130…. Hauptthemen laut MEDLINE: Nanomedicine, Neoplasms. Die Arbeit wurde bisher 80-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, Youth Innovation Promotion Association of the Chinese Academy of Sciences.
Abstract (Originalsprache)
Tumor cells movement and migration are inseparable from the integrity of lipid rafts and the formation of lamellipodia, and lipid rafts are also a prerequisite for the formation of lamellipodia. Therefore, destroying the lipid rafts is an effective strategy to inhibit tumor metastasis. Herein, a multi‐enzyme co‐expressed nanomedicine: cholesterol oxidase (CHO) loaded Co─PN 3 single‐atom nanozyme (Co─PN 3 SA/CHO) that can up‐regulate cellular oxidative stress, disrupt the integrity of lipid rafts, and inhibit lamellipodia formation to induce anti‐metastasis tumor therapy, is developed. In this process, Co─PN 3 SA can catalyze oxygen (O 2 ) and hydrogen peroxide (H 2 O 2 ) to generate reactive oxygen species (ROS) via oxidase‐like and Fenton‐like properties. The doping of P atoms optimizes the adsorption process of the intermediate at the active site and enhances the ROS generation properties of nanomedicine. Meantime, O 2 produced by catalase‐like catalysis can combine with excess cholesterol to generate more H 2 O 2 under CHO catalysis, achieving enhanced oxidative damage to tumor cells. Most importantly, cholesterol depletion in tumor cells also disrupts the integrity of lipid rafts and inhibits the formation of lamellipodia, greatly inhibiting the proliferation and metastasis of tumor cells. This strategy by up‐regulating cellular oxidative stress and depleting cellular cholesterol constructs a new idea for anti‐metastasis–oriented cancer therapy strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin, 130022, P. R. China.
- School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei, Anhui, 230026, P. R. China.
- Department of Chemistry, Tsinghua University, Beijing, 100084, P. R. China.
ORCID-Profile: Yinghui Wang
Förderung
- National Natural Science Foundation of China
- National Key R&D Program of China
- Youth Innovation Promotion Association of the Chinese Academy of Sciences
- Key Technologies Research and Development Program
- National Key Research and Development Program of China
Zitieren
APA
Liu, Y., Niu, R., Deng, R., Wang, Y., Song, S., & Zhang, H. (2024). Multi‐Enzyme Co‐Expressed Nanomedicine for Anti‐Metastasis Tumor Therapy by Up‐Regulating Cellular Oxidative Stress and Depleting Cholesterol. Advanced Materials. https://doi.org/10.1002/adma.202307752
Vancouver
Liu Y, Niu R, Deng R, Wang Y, Song S, Zhang H. Multi‐Enzyme Co‐Expressed Nanomedicine for Anti‐Metastasis Tumor Therapy by Up‐Regulating Cellular Oxidative Stress and Depleting Cholesterol. Advanced Materials. 2024. doi:10.1002/adma.202307752
BibTeX
@article{Liu2024,
author = {Liu, Yang and Niu, Rui and Deng, Ruiping and Wang, Yinghui and Song, Shuyan and Zhang, Hongjie},
title = {Multi‐Enzyme Co‐Expressed Nanomedicine for Anti‐Metastasis Tumor Therapy by Up‐Regulating Cellular Oxidative Stress and Depleting Cholesterol},
journal = {Advanced Materials},
year = {2024},
doi = {10.1002/adma.202307752}
}
EUVIMED